Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

NNC0519-0130

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Novo Nordisk · Phase 1 · Completed · Enrollment 161

NCT05363774

EudraCT 2021-004856-41

ArmPopulationDoseWeeksEstimandWeight change
Single ascending dose (SAD) partT2D onlyn/r18n/rn/r
Multiple ascending dose (MAD) QD partT2D onlyn/r18n/rn/r
Type 2 diabetes (T2D) partT2D onlyn/r18n/rn/r
MAD QW partT2D onlyn/r18n/rn/r